1,2-dioleoyl-sn-glycero-3-phospho-L-serine

Metabolite details

Identifier

WTBFLCSPLLEDEM-JIDRGYQWSA-N

InChI Key

WTBFLCSPLLEDEM-JIDRGYQWSA-N

IUPAC name

O-[({(2R)-2,3-bis[(9Z)-octadec-9-enoyloxy]propyl}oxy)(hydroxy)phosphoryl]-L-serine

Preferred name

1,2-dioleoyl-sn-glycero-3-phospho-L-serine

INN name

—

Synonym

DOPSE

ChEBI

CHEBI:60568

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity
• 4-Octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Control_12h_vs_Toxocara canis_12h
• Control_vs_Palmitate
• Control_vs_DMXAA16h
• wild_type_vs_patA_deletion
• BSA_Control_vs_AA